Ott, M. G., Marmé, F., & Moldenhauer, G. (2012). Humoral response to catumaxomab correlates with clinical outcome: Results of the pivotal phase II/III study in patients with malignant ascites. International journal of cancer, 130(9), . https://doi.org/10.1002/ijc.26258
Chicago Style (17th ed.) CitationOtt, Marion Gabriele, Frederik Marmé, and Gerhard Moldenhauer. "Humoral Response to Catumaxomab Correlates with Clinical Outcome: Results of the Pivotal Phase II/III Study in Patients with Malignant Ascites." International Journal of Cancer 130, no. 9 (2012). https://doi.org/10.1002/ijc.26258.
MLA (9th ed.) CitationOtt, Marion Gabriele, et al. "Humoral Response to Catumaxomab Correlates with Clinical Outcome: Results of the Pivotal Phase II/III Study in Patients with Malignant Ascites." International Journal of Cancer, vol. 130, no. 9, 2012, https://doi.org/10.1002/ijc.26258.